Skip to main content

Table 3 Patients at low risk in primary prevention

From: From hypertension control to global cardiovascular risk management: an educational intervention in a cluster-randomised controlled trial

  Complex intervention A n = 366 Simple intervention B n = 384 A vs. B
  Mean FU 95% CI Mean FU 95% CI Difference/Odds ratio 95% CI p ICC p
CVR 2.9% 2.7%-3.1% 2.7% 2.5%-2.9% Δ = 0.2% -0.1%-0.5% 0.282 0.032 0.043
RR systolic [mmHg] 134.0 132.1-135.9 134.3 132.3-136.2 Δ = -0.2 -2.9-2.5 0.866 0.097 <0.001
RR diastolic [mmHg] 80.9 79.9-82.0 80.7 79.7-81.8 Δ = 0.2 -1.3-1.7 0.798 0.063 <0.001
Control rate RR < 140/90 58.1% 51.3%-64.8% 54.0% 47.1%-60.9% OR = 1.19 0.78-1.82 0.411 0.098 <0.001
Control rate RR < 160/95 90.2% 86.8%-93.6% 90.7% 87.4%-94.0% OR = 0.94 0.55-1.62 0.830 0.051 0.205
Cholesterol [mg/dl] 216.6 213.0-220.1 219.3 215.7-222.8 Δ = -2.7 -7.7-2.3 0.294 0.021 0.103
Current smoker 16.2% 12.5%-20.0% 16.4% 12.5%-20.3% OR = 0.98 0.48-1.99 0.948 0.240 <0.001
ASS 9.0% 7.0%-10.9% 9.2% 7.3%-11.2% OR = 0.89 0.32-2.43 0.815 0.318 0.001
Statins 18.1% 14.6%-21.6% 13.5% 10.2%-16.7% OR = 1.89 0.98-3.62 0.056 0.150 0.010
  1. Outcomes at follow up in subpopulation at low CVR (10-year mortality < 5%) with no manifest CVD (complete cases), adjusted for baseline and taking cluster effects into account by use of a mixed model.